149980.KQ

Strong BuyUnloved QualityAI neutral

Hironic Co., Ltd. · Healthcare · South Korea · $59M cap · $67K/day traded

KRW 4,215 +1.8% · close 19 Oct · scored 20 Oct

StockRank up 1.6 since 17 Oct.

Unloved Quality: Strong and cheap; the market has not turned yet.

90
StockRank
Get score and insider alerts
Quality
75
Value
77
Momentum
39

As of 20 Oct 2026, MoatMap's StockRank for Hironic Co., Ltd. (149980.KQ) is 90/100, ranked against 24,000+ stocks in 35 markets (Quality 75, Value 77, Momentum 39, each scored against its sector).

Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →

P/E (TTM)
19.3x
peers 15.9x
ROE
6.3%
peers -0.3%
D/E
0.0x
peers 0.3x
Dividend %
5.6%
trailing yield
AI CONVICTION THESIS

Hironic is a small Korean maker of aesthetic and beauty medical devices. The quality and value scores are respectable, but there is no current news to confirm demand trends, export momentum or product pipeline, and price momentum is weak. At around $59M market value, the evidence available is too thin to establish a durable competitive advantage.

ABOUT HIRONIC CO., LTD.

Read

Hironic Co., Ltd. engages in the manufacture and sale of medical and surgical equipment, and other orthopedic appliances in South Korea and internationally. It offers its products for the MFU and RF, laser, plasma, and cryotherapy.

FINANCIAL SUMMARY (KRW)

Year20212022202320242025CAGRTTM
Revenue—27.6B33.7B31.6B32.1B5.2%37.0B
EPS (KRW)—169.70421.67-424.00215.008.2%214.69
Shares—16.3M16.8M16.8M14.6M-10.4%17.2M
Debt2.7B2.8B26.8M—1.4B-14.7%164.0M
Equity—59.8B72.3B68.2B63.5B2.0%—
Op CF—4.5B-1.1B5.5B-88.1M10.8%1.9B
Inv CF—-4.3B3.3B-1.5B-980.2M——
Fin CF—-78.1M-103.2M-7.2B1.2B——
Loading 1Y...
PRICE (1Y) · KRW-14.2%
4,1004,3044,5084,7114,9152 Sep23 Sep19 Oct
SMA 50SMA 200

Price checkFinding a floorExperimental

No new 52-week low for 12 weeks, 12% above that low, but not back above a rising 50-day average.

SwingsVery bumpy

Swung more than 76% of stocks we rank over the past year (61% a year).

How this is worked out

StockRank judges the business. The price check reads only the chart: it is the price side of the Momentum score, in words.

The rules: Still falling is a new 52-week low in the last two weeks, at least 25% below the high. Finding a floor is no new low since. Turning up is 20 or more trading days without a new low, at least 10% off it, and back above a rising 50-day average. In an uptrend is above the 200-day average and within 15% of the high.

In 2,112 US drawdowns since 2001, buying while the price was still falling was followed by a further 20% drop 42% of the time. Waiting for a turn like this one cut that to 33%, at about 7% higher prices and with no better returns. Part of that cut is simply not buying: 13% of falls never turned, and waiting kept those out. Among turns that were bought, 38% still fell another 20%, and 33% of turns were followed by a new low within six months. The benefit was largest in crashes such as 2008 and 2020.

What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.

What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.

Calm is not safe: a calm stock can still slide steadily.

Rules fixed before any data was fetched. Describes the chart, not a recommendation.

Close
KRW 4,215
RSI (14)
33.9
52-Week Range-53.4% from high
Low KRW 3,770High KRW 9,039.05

SCORE BREAKDOWN

Quality
75
ROIC
6.4%58.4
ROE
6.3%58.1
GP/Assets
37.8%76.6
Op. Margin
10.2%63.3
FCF/Assets
8.9%82.8
Piotroski
677.0
Int. Cover
50.0x89.4
D/E Ratio
0.00x92.4
Current Ratio
8.80x85.1
Value
77
P/E (TTM)
19.3x61.6
EV/EBITDA
6.9x83.3
P/FCF
14.4x73.9
P/B
1.0x84.8
P/S
1.9x68.6
Div Yield
5.6%93.7
Momentum
39
52W High %
47%23.4
RS 6M
-11%54.6
SMA 50/200
0.99x55.4
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$59M
P/E (Forward)
—
Gross Margin
62.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 149980.KQ are excluded.

TickerCompanyMkt CapStockRankSignal
149980.KQHironic Co., Ltd.(you)$59M90Strong Buy
104540.KQCorentec Co., Ltd.$55M94Strong Buy
228850.KQRayence Co., Ltd.$92M90Strong Buy
004080.KSShinhung Co., Ltd$100M82Strong Buy
206640.KQBoditech Med Inc.$150M85Strong Buy
226400.KQOSTEONIC Co., Ltd.$59M61Hold
100120.KQVieworks Co., Ltd.$164M100Strong Buy
054950.KQJVM Co., Ltd.$196M99Strong Buy
065510.KQHuvitz Co., Ltd.$51M51Hold
336570.KQWON TECH Co.,Ltd.$316M81Strong Buy

Peer medians: ROE -0.3% · P/E 15.9x · Gross margin 43.2%

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

Hironic Co., Ltd. (149980.KQ): Stock Score Summary

Hironic Co., Ltd. (149980.KQ) has a MoatMap StockRank of 90/100 based on Quality (75/100), Value (77/100), and Momentum (39/100) factor scores. The current signal is STRONG BUY. Hironic is a small Korean maker of aesthetic and beauty medical devices. The quality and value scores are respectable, but there is no current news to confirm demand trends, export momentum or product pipeline, and price momentum is weak. At around $59M market value, the evidence available is too thin to establish a durable competitive advantage.

Hironic Co., Ltd. engages in the manufacture and sale of medical and surgical equipment, and other orthopedic appliances in South Korea and internationally. It offers its products for the MFU and RF, laser, plasma, and cryotherapy.

Key Financial Metrics

PriceKRW 4,215
Market Cap$59M
P/E (TTM)19.26
Price/Book0.95
Return on Equity6.3%
Return on Invested Capital6.4%
Debt/Equity0.00x
Gross Margin62.8%
Operating Margin10.2%
Revenue Growth36.9%
Dividend Yield5.6%
Free Cash Flow$4M

Hironic Co., Ltd. operates in the Medical Devices industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Hironic Co., Ltd.’s (149980.KQ) StockRank?
MoatMap’s StockRank for Hironic Co., Ltd. (149980.KQ) is 90/100, with a Strong Buy signal. It is a composite of Quality (75), Value (77), and Momentum (39), each scored against its sector. The composite is then ranked across MoatMap’s universe of 24,000+ stocks.
Does Hironic Co., Ltd. have an economic moat?
Hironic Co., Ltd. (149980.KQ) has a Quality factor score of 75/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Hironic Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Hironic Co., Ltd. (149980.KQ) is Strong Buy, based on a StockRank of 90/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Hironic Co., Ltd. in?
Hironic Co., Ltd. (149980.KQ) operates in the Healthcare sector, specifically the Medical Devices industry (South Korea).